Human Circadian Phenotyping and Diurnal Performance Testing in the Real World.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
07 04 2020
Historique:
entrez: 28 4 2020
pubmed: 28 4 2020
medline: 22 9 2020
Statut: epublish

Résumé

In our continuously developing 'around the clock' society, there is a need to increase our understanding of how changes in biology, physiology and psychology influence our health and performance. Embedded within this challenge, is the increasing need to account for individual differences in sleep and circadian rhythms, as well as to explore the impact of time of day on performance in the real world. There are a number of ways to measure sleep and circadian rhythms from subjective questionnaire-based methods to objective sleep/wake monitoring, actigraphy and analysis of biological samples. This paper proposes a protocol that combines multiple techniques to categorize individuals into Early, Intermediate or Late circadian phenotype groups (ECPs/ICPs/LCPs) and recommends how to conduct diurnal performance testing in the field. Representative results show large differences in rest-activity patterns derived from actigraphy, circadian phase (dim light melatonin onset and peak time of cortisol awakening response) between circadian phenotypes. In addition, significant differences in diurnal performance rhythms between ECPs and LCPs emphasizes the need to account for circadian phenotype. In summary, despite the difficulties in controlling influencing factors, this protocol allows a real-world assessment of the impact of circadian phenotype on performance. This paper presents a simple method to assess circadian phenotype in the field and supports the need to consider time of day when designing performance studies.

Identifiants

pubmed: 32338646
doi: 10.3791/60448
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/J014532/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204846/Z/16/Z
Pays : United Kingdom

Auteurs

Elise R Facer-Childs (ER)

Chronobiology, Faculty of Health & Medical Sciences, University of Surrey; Centre for Human Brain Health, University of Birmingham; Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University; Elise.Facer-Childs@monash.edu.

Benita Middleton (B)

Chronobiology, Faculty of Health & Medical Sciences, University of Surrey.

Andrew P Bagshaw (AP)

Centre for Human Brain Health, University of Birmingham.

Debra J Skene (DJ)

Chronobiology, Faculty of Health & Medical Sciences, University of Surrey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH